PGR and invasive ductal breast carcinoma: Furthermore, an enhanced expression of cyclin D1 was also observed in 67.5% of invasive ductal carcinoma cases, where it was strongly correlated with estrogen receptor (ER) and progesterone receptor (PR) expression [38].